Percutaneous removal of endocardial implantable cardioverter-defibrillator lead displaced to the right pulmonary artery by Małecka, Barbara et al.
www.cardiologyjournal.org 293
CASE REPORT
Cardiology Journal
2010, Vol. 17, No. 3, pp. 293–298
Copyright © 2010 Via Medica
ISSN 1897–5593
Address for correspondence:  Barbara Małecka, Department of Electrocardiology, Institute of Cardiology, CMUJ,
John Paul II Hospital in Krakow, Prądnicka 80, 31–202 Kraków, Poland, e-mail: barbara_malecka@o2.pl
Received: 9.03.2009 Accepted: 8.05.2009
Percutaneous removal of endocardial
implantable cardioverter-defibrillator
lead displaced to the right pulmonary artery
Barbara Małecka1, Andrzej Kutarski2, Andrzej Ząbek1,
Andrzej Maziarz1, Mariusz Pytkowski3
1Department of Electrocardiology, Institute of Cardiology, Jagiellonian University Collegium Medicum,
John Paul II Hospital in Krakow, Krakow, Poland
2Chair and Department of Cardiology, Medical University, Lublin, Poland
3Coronary Disease Department, Institute of Cardiology, Warszawa, Poland
Abstract
We describe a case of percutaneous removal of endocardial implantable cardioverter-defibrilla-
tor lead displaced to the right pulmonary artery. The procedure was performed from two
accesses; from the lower one (femoral) and then, due to technical problems, from the upper one
(subclavian). In the last stage the flattened Dotter’s basket was introduced to the heart inside
the Byrd dilator and then fastened to the described lead as the external ‘splint’. This solution is
an alternative to the recommended use of the internal metal leader with anchoring function in
case of significant malformation of the internal lumen of the lead. The procedure we describe is
an example of the sort of individual, original solution indispensable for the efficient and safe
removal of untypically displaced leads. (Cardiol J 2010; 17, 3: 293–298)
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Introduction
Percutaneous endocardial lead removal is be-
coming common among patients with pacemakers
(PPM) or defibrillators (ICD). General indications
for lead removal were included in HRS 2009 (Heart
Rhythm Society) recommendations [1]. The tech-
nique of percutaneous lead removal uses two ways
of access to the heart, upper and lower. Upper ac-
cess through the subclavian veins is reserved for
the leads with proximal ends accessible from the
PPM/ICD pocket, while lower access through the
femoral veins is preferable for the migrating or
strongly ingrown leads in to the cardiovascular
walls. Assessment of the particular anatomy and
mutual lead position determines which access is
chosen. Sometimes a sudden change of access route
is necessitated by procedural technical difficulties.
The presented case of a 27 year-old woman is an
example of the need to create ad hoc solutions in-
volving a change of access route.
Case description
A 27 year-old woman, treated with permanent
defibrillation for ten years, was qualified for the
procedure after being saved from a ventricular
fibrillation episode. In this case, the indication for
the implantation was the prophylaxis of secondary
sudden cardiac death in a patient with hypertrophic
cardiomyopathy. A single-lead system, implanted
through the subclavian vein, consisting of a one-coil,
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silicone-insulated, passive fixation lead, was con-
nected to the cadioverter in the subcutaneous pock-
et of the left subclavian region.
Five years after system implantation, includ-
ing 16 months after planned cardioverter-defibril-
lator exchange, the purulence of the pocket oc-
curred. That was the reason for what was then, and
unfortunately is often still today, seen as the opti-
mal  solution. The attempt at direct traction proved
unsuccessful. Therefore, the lead was shortened by
cutting it off the cardioverter and ‘secured in the
tissues’ of the subclavian region. This was believed
to become a satisfactory separation of the shortened
lead from the pocket infection.
We assume such management to be faulty be-
cause the range of infection on the lead is difficult
or even impossible to assess. Moreover, the unsuc-
cessful attempt at a direct traction was the reason
for the deformation of the internal lead lumen as
well as faulty tension in it, which most probably trig-
gered the subsequent dislocation to the large blood
vessels and the heart. The cardioverter was re-
moved from the pocket with simultaneous implan-
tation, via the right subclavian vein, of a single-lead,
double-coil system of passive fixation together with
the cardioverter installation into the subcutaneous
pocket under the right clavicle.
Over the following years, the patient gave birth
to two children, both by Caesarean section. She
underwent periodic, adequate anti-arrhythmic inter-
ventions.
A few weeks before admission to the clinic,
irregular electric discharges and noises received by
the lead indicated the impairment of the functioning
lead. Diagnostics revealed the displacement of the left
lead end to the right pulmonary artery (Fig. 1A, B).
Retrospective analysis indicated a dislocation of no
clinical significance having occurred a few years
before. Such a diagnosis was based on doctor’s in-
vestigations, chest X-ray, echocardiography and lab
tests, none of which revealed chronic pulmonary
embolism.
It was decided to remove the old implanted
right lead. The removal of the inactive lead dis-
located to the pulmonary bed was also believed
necessary, despite its current clinical insignifi-
cance.
Lead removal procedure
The procedure was initiated by removal of the
displaced lead.
Step 1
We decided to use the Scout Pro 7 F (Biotronik)
set (Fig. 2) instead of Byrd Workstation [2] to be
installed to the left femoral vein for that purpose.
Via the set, the pigtail 6 F (Cordis) with the lead
Figure 1. Chest X-ray before the leads’ removal: A. Posterior-anterior projection; B. Lateral projection; arrow 1 —
displaced lead; arrow 2 — right-side lead.
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winded onto it was retracted to the vena cava infe-
rior (Fig. 3A, B). The Dotter’s basket [2] was inserted
from the same access and opened in the vicinity of
the freely moving proximal end of the lead (Fig. 3C).
The end was grasped and attempted to be torn off
the right endocardium adhesion. However, the coil
and the head were so much ingrown to the endo-
cardium that releasing it from the lower access  by
the above procedure could only be done by pulling
it to pieces.
Step 2
The lead was caught once again by the Dotter’s
basket and Scout Pro 7 F was removed. We intro-
duced the white Byrd dilator on the Dotter’s bas-
ket which was visible outside patient’s body as it
served the protrusion of the lead. We used one of
five polypropylene Byrd dilators. White colour in-
dicates inner sheath ID/OD 11.5/13.6 F and outer
sheath ID//OD 14.1/16.3 F (Fig. 3D, E) [2]. The 41/
/46 cm long dilator used in the procedure proved to
be too short by 5 cm, however (Fig. 3F). A change
of access from lower to upper, by the subclavian
vein, was instantly decided upon.
Figure 2. Operative field picture: the Scout Pro 7 F Bio-
tronik set.
Figure 3. Intrasurgical figures. A. Fluoroscopy: winding of the lead on the pigtail in the lumen of the right ventricle;
B. Fluoroscopy: the pigtail pulls the lead to the vena cava inferior; C. The free end of the lead in the vena cava inferior
is caught by Dotter’s basket; D. Operative field picture: a white Byrd dilator being introduced along the Dotter’s
basket’s rod from the left femoral vein access; E. Fluoroscopy: a white Byrd dilator on the lead caught by the Dotter’s
basket; arrow: end of the dilator’s sheath; F. Fluoroscopy: the white Byrd dilator sheath reaching the beginning of
the coil of the lead only, a few centimeters from the distal lead’s end; arrow: end of the dilator sheath.
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Step 3
At first, access from the left subclavian vein
was suggested in order to avoid traumatizing the
right region. However, the intrasurgical venogra-
phy revealed the obliteration of the vein (Fig. 4A).
Therefore the access was changed for the right
subclavian vein with the use of Seldinger’s tech-
nique. Through the lumen of the inserted sheath
via Seldinger’s technique, the Dotter’s basket was
introduced and used to grasp the lead’s end
(Fig. 4B). The sheath which disturbed the lead-
-basket complex removal from the subclavian vein
was taken off. Immediately the Dotter’s basket
allowed to expose the lead to be seen outside the
body (Fig. 4C).
Step 4
With the lead outside the subclavian vein, the
ligatures were tied to it in order to remove the
whole lead (Fig. 4C). The recommended specialist
anchoring leader (e.g. Liberator Cook) was not
passed into the vein lumen due to significant length-
ening of the lead itself which narrowed its lumen.
The deformation of the lead was the result of the
direct traction procedure performed 5 years previ-
ously, as well as our present actions.
Step 5
At the later stage of the procedure the newly
created construction, i.e, the lead with the ligatures,
was inserted into the white Byrd dilator (Fig. 4D).
Unfortunately the whole ’device‘ proved to be not
strong enough and did not create an adequate coun-
tertraction for excision of the lead from the adhe-
sions in the heart. To help the situation, the con-
struction was strengthened by inserting the flat-
tened Dotter’s basket into the Byrd dilator.
Simultaneously passing the lead through the mesh-
es of the Dotter’s basket while inserting it to the
dilator’s sheath, the basket was finally fully fastened
on the lead, a few cm from the ventricular lead coil
(Fig. 4E). In this way, external lead strengthening,
a sort of ‘splint’, was achieved, which enabled
a successful excision and removal of the whole lead
from the heart (Fig. 4E–H).
A week later, removal of the right lead, which
proved to be technically easier and more straight-
forward, was undertaken (Fig. 5A). The lead had its
Figure 4. Intrasurgical figures. A. Fluoroscopy: left-side venography presenting no lumen in the left subclavian vein
and well-developed collateral circulation; B. Fluoroscopy: Dotter’s basket introduced by the right subclavian vein
catches the lead (arrow); C. Operative field picture: a removed proximal lead’s end with double ligatures tied to it
removed outside the vein outlet; D. Fluoroscopy: Byrd dilator sheath on the lead; arrow: end of the dilator sheath;
E. Fluoroscopy: Byrd dilator on the lead with the visible closed Dotter’s basket inside the Byrd dilator sheath; arrow:
a closed Dotter‘s basket; F. A final stage of cutting the lead from the adhesions; arrow: end of the dilator sheath;
G. Fluoroscopy: the torn off lead in one piece visible inside the Byrd dilator sheath; arrow 1 — Byrd dilator’s sheath
leaning against the endocardium; arrow 2 — lead’s distal end inside the sheath; H. The removed lead after the
procedure.
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proximal end accessible from the cardioverter pock-
et which enabled its removal with the use of the
internal leader and white Byrd dilator (Fig. 5B–D).
At that point, the Seldinger system was installed for
implantation of the new ICD lead (Fig. 5E). The pa-
tient left hospital with a new ICD system installed and
has been under the care of her home cardiology cent-
er. She has been in good general condition so far.
Discussion
There may be several reasons why adhesion
to the pulmonary artery after years of leads pre-
sence there was not so strong. It has often been not-
ed that extremely strong adhesions were created
at the contact place of proximal displaced leads ends
and great vein vessels [3, 4]. Weak adhesions could
be because of:
— a different structure of the artery wall as op-
posed to the vein wall;
— different dynamics of blood current;
Figure 5. Intrasurgical figures. A. Fluoroscopic picture of the heart before the second lead removal; arrow: right-side
lead; B. Fluoroscopy: the Byrd dilator introduced along the lead from the right cardioverter pocket access; arrow:
end of the dilator sheath; C. Fluoroscopy: a torn off lead visible inside the white Byrd dilator sheath; D. The removed
lead protruding from the white Byrd dilator sheath; E. A fluoroscopic picture of the heart after a new lead implantation.
— a ‘safe’ proximal lead’s end’s existence when
the torn off, metal wire was deep inside the si-
licone insulation.
Regarding this third reason, long ago we ob-
served a case of displacement of the lead through
the heart chambers culminating in the death of the
patient [5]. The lead destroyed between the clavicle
at the first rib i.e. in crush syndrome was torn off
and pushed to the pulmonary artery by the blood
current. The torn off end with the unwound metal
wire could be compared to a bottle brush in the car-
diovascular system tearing off the endothelium of
the atrium. As a result, there was a partial oblite-
ration of the atrium and creation of a cluster of gran-
ulation in a pulmonary artery. The granulation re-
sulted in pulmonary embolism. Bearing the current-
ly described case in mind, we believe that the fact
that the metal wire end was hidden deep in the in-
sulation saved the endothelium. We also suppose
that the displacement of the infected proximal end
resulted in the lead dependent vasculitis and obli-
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teration of the left subclavian vein. It could be the
reaction of the organism to separate the pocket pu-
rulence from the endocardium. In the described
case, several original modifications of the removal
procedure were used. Literature has not thus far
presented any use of Byrd dilator from the lower
access with the construction consisting of the Dot-
ter’s basket and the lead grasped by it. We think it
is possible to remove the lead from such access
using the above modification but with a longer dila-
tor. We disagree with opinions of the lead removal
constructors that the use of counter traction by the
Byrd workstation from the lower access only is suf-
ficient to remove the lead from the adhesions to the
heart and blood vessels with no need to use rota-
tion-cutting forces of Byrd dilators. The purely the-
oretical opinion leads to the production of Byrd di-
lators only in two lengths sufficient for upper ac-
cess but not always for the lower access.
Despite this, we have in the past successfully
performed lead removals using a Byrd dilator from
the lower access [6]. During the presented proce-
dure there was also a need for the use of dilator from
the lower access. This could not however be
achieved, due to its insufficient length. It was also
proved that an alternative technique to an internal
anchoring leader is possible. In case of significant
malformation of the lead, a well proven technique
of ours is an external strengthening of the lead cre-
ating a kind of ’splint‘ which enables its grasping in
case of displacement. In the presented case, the
Dotter’s basket constituted the ’splint‘ as it was
a metal rod with an additional strong external mo-
vable grasping point on the electrode.
Conclusions
1. The lead displaced to the pulmonary artery can
be removed percutaneously.
2. The removal of so-called ‘difficult leads’ requi-
res the use of individual, original technical so-
lutions.
3. Accessible instruments do not satisfy all the
possible needs resulting from technical and
anatomical conditions.
4. In particular, there is a shortage of longer Byrd
dilators as well as external anchoring leaders
for cases when malformed lead lumen blocks
the internal anchoring leaders such as ‘Locking
Stylet’ or ‘Liberator’ from entering the lead.
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